Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's disease
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's disease. / Mullari, Meeli; Fossat, Nicolas; Skotte, Niels H; Asenjo-Martinez, Andrea; Humphreys, David T; Bukh, Jens; Kirkeby, Agnete; Scheel, Troels K H; Nielsen, Michael L.
In: Nature Communications, Vol. 14, 4348, 2023.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's disease
AU - Mullari, Meeli
AU - Fossat, Nicolas
AU - Skotte, Niels H
AU - Asenjo-Martinez, Andrea
AU - Humphreys, David T
AU - Bukh, Jens
AU - Kirkeby, Agnete
AU - Scheel, Troels K H
AU - Nielsen, Michael L
N1 - © 2023. The Author(s).
PY - 2023
Y1 - 2023
N2 - RNA-binding proteins (RBPs) are key players regulating RNA processing and are associated with disorders ranging from cancer to neurodegeneration. Here, we present a proteomics workflow for large-scale identification of RBPs and their RNA-binding regions in the mammalian brain identifying 526 RBPs. Analysing brain tissue from males of the Huntington's disease (HD) R6/2 mouse model uncovered differential RNA-binding of the alternative splicing regulator RBM5. Combining several omics workflows, we show that RBM5 binds differentially to transcripts enriched in pathways of neurodegeneration in R6/2 brain tissue. We further find these transcripts to undergo changes in splicing and demonstrate that RBM5 directly regulates these changes in human neurons derived from embryonic stem cells. Finally, we reveal that RBM5 interacts differently with several known huntingtin interactors and components of huntingtin aggregates. Collectively, we demonstrate the applicability of our method for capturing RNA interactor dynamics in the contexts of tissue and disease.
AB - RNA-binding proteins (RBPs) are key players regulating RNA processing and are associated with disorders ranging from cancer to neurodegeneration. Here, we present a proteomics workflow for large-scale identification of RBPs and their RNA-binding regions in the mammalian brain identifying 526 RBPs. Analysing brain tissue from males of the Huntington's disease (HD) R6/2 mouse model uncovered differential RNA-binding of the alternative splicing regulator RBM5. Combining several omics workflows, we show that RBM5 binds differentially to transcripts enriched in pathways of neurodegeneration in R6/2 brain tissue. We further find these transcripts to undergo changes in splicing and demonstrate that RBM5 directly regulates these changes in human neurons derived from embryonic stem cells. Finally, we reveal that RBM5 interacts differently with several known huntingtin interactors and components of huntingtin aggregates. Collectively, we demonstrate the applicability of our method for capturing RNA interactor dynamics in the contexts of tissue and disease.
KW - Mice
KW - Male
KW - Animals
KW - Humans
KW - Huntington Disease/genetics
KW - Brain/metabolism
KW - RNA-Binding Proteins/genetics
KW - Disease Models, Animal
KW - Mammals/genetics
KW - RNA/metabolism
KW - Huntingtin Protein/genetics
KW - Mice, Transgenic
KW - DNA-Binding Proteins/metabolism
KW - Cell Cycle Proteins/metabolism
KW - Tumor Suppressor Proteins/genetics
U2 - 10.1038/s41467-023-39936-x
DO - 10.1038/s41467-023-39936-x
M3 - Journal article
C2 - 37468457
VL - 14
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 4348
ER -
ID: 360243786